Sign in to continue:

Saturday, February 7th, 2026

Medinex Limited Announces 0.84 Cents Interim Dividend for FY2025 – Key Dates for Shareholders








Medinex Limited Announces Interim Dividend Payment Date

Medinex Limited Announces Interim Dividend Payment Date

In a recent disclosure, Medinex Limited, incorporated in the Republic of Singapore, has announced its decision to distribute an interim dividend of 0.84 Singapore cents per ordinary share for the financial year ending 31 March 2025. This announcement is significant for shareholders and potential investors, as dividends can impact share valuation and investor sentiment.

Key details from the announcement include:

  • The share transfer books and the register of members will close at 5.00 p.m. on 07 January 2025. This is crucial for determining shareholders’ entitlement to the interim dividend.
  • Only duly completed transfers of shares received by the Company’s Share Registrar, Tricor Barbinder Share Registration Services, by the cut-off time will be considered for dividend eligibility.
  • Shareholders whose securities accounts with The Central Depository (Pte) Limited are credited with shares as of 5.00 p.m. on the same date will also be entitled to receive the dividend.
  • The interim dividend payment is scheduled for 20 January 2025.

This announcement was made on 14 November 2024 by Jessie Low Mui Choo, the Executive Director and Chief Executive Officer of Medinex Limited.

While this announcement is a routine corporate disclosure, the confirmation of a dividend may influence the stock price as it reflects the company’s financial health and its ability to return profits to its shareholders. Investors often view dividend payments as a sign of a company’s stable financial performance.

For further inquiries, shareholders can contact Mr. Pong Chen Yih, Chief Operating Officer at Novus Corporate Finance Pte. Ltd., the company’s sponsor, at 7 Temasek Boulevard, #04-02 Suntec Tower 1, Singapore.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. Investors should conduct their own research or consult with a financial advisor before making any investment decisions.




View Medinex Historical chart here



Hyphens Pharma Sees Mixed Q3 Results Amid Strong Year-to-Date Growth

Hyphens Pharma International Posts Strong Revenue Growth and Profit Boost in 2024 Hyphens Pharma International Posts Strong Revenue Growth and Profit Boost in 2024 Hyphens Pharma International Limited (SGX: HYPH) has released its quarterly...

Civmec Limited 2025 AGM Minutes: Director Re-Election, Share Issuance Authority, and Strategic Business Updates

Civmec Limited AGM 2025: Key Highlights and Investor Insights Civmec Limited AGM 2025: Key Highlights and Investor Insights Overview of the AGM Civmec Limited held its Annual General Meeting (AGM) on 30 October 2025...

Bromat Holdings Ltd Receives Statutory Demand Over Outstanding Settlement Sum from Sandbox Studio Pte Ltd 1

Bromat Holdings Ltd. Receives Statutory Demand from Sandbox Studio Pte Ltd Bromat Holdings Ltd. Faces Statutory Demand Over Unpaid Settlement Sum Key Points: On 17 November 2025, Bromat Holdings Ltd. and its subsidiaries (“the...